Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Non-invasive biomarkers for early diagnosis of pancreatic cancer risk: metabolite genomewide association study based on the KCPS-II cohort

4 Dec 2023

Abstract excerpt

BACKGROUND: Pancreatic cancer is a lethal disease with a high mortality rate. The difficulty of early diagnosis is one of its primary causes. Therefore, we aimed to discover non-invasive biomarkers that facilitate the early diagnosis of pancreatic cancer risk. METHODS: The study subjects were randomly selected from the Korean Cancer Prevention Study-II and matched by age, sex, and blood collection point...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Metabolomics and Mass Spectrometry Studies
Share to Pancreatic and Hepatic Oncology Research
Share to Pancreatitis Pathology and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38049855
DOI: 10.1186/s12967-023-04670-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Non-invasive biomarkers for early diagnosis of pancreatic cancer risk: metabolite genomewide association study based on the KCPS-II cohortPMID 38049855Read ↗

Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic challenges.Semantic proximity Read ↗

Development of a 12-biomarkers-based prognostic model for pancreatic cancer using multi-omics integrated analysis.Semantic proximity Read ↗

Current State of “Omics” Biomarkers in Pancreatic CancerSemantic proximity Read ↗

Early detection of pancreatic cancer: Where are we now and where are we going?Semantic proximity Read ↗

Metabolic Syndrome Related Gene Signature Predicts the Prognosis of Patients With Pancreatic Ductal Carcinoma. A Novel Link Between Metabolic Dysregulation and Pancreatic Ductal Carcinoma.Semantic proximity Read ↗

Integrating plasma protein-centric multi-omics to identify potential therapeutic targets for pancreatic cancer.Semantic proximity Read ↗

The exposome and pancreatic cancer, lifestyle and environmental risk factors for PDAC.Semantic proximity Read ↗

A metabolism-relevant signature as a predictor for prognosis and therapeutic response in pancreatic cancer.Semantic proximity Read ↗

Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancerSemantic proximity Read ↗

Elevated circulating glycine levels are associated with reduced pancreatic cancer risk: A prospective cohort study based on the UK biobank.Semantic proximity Read ↗

A comprehensive assessment of single nucleotide polymorphisms associated with pancreatic cancer risk: A protocol for systematic review and network meta-analysis.Semantic proximity Read ↗

[Significance of precision medicine in pancreatic cancer prevention and treatment].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.